Agenus Inc

Agenus CEO Dr. Garo H. Buys 4,829 Shares, Doubling His Stake—Insider Buying Signals Confidence in Immuno‑Oncology Pipeline and Possible Upswing in Stock Price

Insider buying surge at Agenus Inc. shows CEO Armen Garo purchasing 4,829 shares, signaling confidence in the biotech’s immuno‑oncology pipeline and potential upside amid market buzz.

Agenus Inc
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

24/02/2026, 22:29

4 minutes to read

Agenus CEO’s Steady Insider Trades Signal Confidence Amid $141 Million Zydus Deal and Ongoing Share‑Price Volatility

Explore how Agenus insider moves and a $141 M partnership with Zydus signal potential upside amid a volatile stock and low P/E.

Agenus Inc
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

16/01/2026, 22:37

4 minutes to read